Detailed price information for Surge Copper Corp (SURG-X) from The Globe and Mail including charting and trades.
Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter ...
FLYING Magazine on MSN
Cirrus Unveils 2026 SR Series G7+ With Advanced Avionics
Cirrus noted the 2026 SR Series G7+ advances connectivity with enhancements to Cirrus Global Connect and higher-power USB-C ...
Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter ...
Fidelity's FQAL is a lesser-known quality-themed fund with a 0.15% expense ratio and $1.2B in assets under management. This ...
Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter ...
The Pioneer on MSN
Centre accelerates inclusive, tech-driven empowerment for persons with disabilities
Union Minister Dr Virendra Kumar stresses inclusive development for persons with disabilities while chairing the 8th Central ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License ...
VnExpress International on MSN
Tech billionaires cash out $16B in 2025: who are the top sellers?
Senior executives including Jeff Bezos, Safra Catz and Jensen Huang carried out major stock sales in 2025 as an artificial intelligence-driven rally lifted technology valuations to historic highs.
Investor's Business Daily on MSN
Coinbase extends losses as Bitcoin hovers near $91,000; is Coin stock a buy now?
Coinbase COIN stock slipped on Friday, on its way to post a four-day losing streak. The stock has been languishing below its ...
Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results